Tips & Expertise: 2022 IPPS Updates Webinar Q&A

Q:  VitalWare is reporting that New Technology Add-on Payment for Abecma and Tecartus but they also drive to DRG 018. How does that work? A:  This is correct.  CAR T-cell therapies are assigned to MS-DRG 018 through a pre-MDC.  Abecma and Tecartus both also receive...